Results 61 to 70 of about 5,545,002 (288)
Impact of high-cost drugs for individual patient use [PDF]
, 2004 To document and describe the individual patient use (IPU) scheme at St Vincent's Hospital, Sydney in terms of submissions and approvals and assess the financial impact of the scheme on the hospital drug expenditure.
Brien, JE +3 more
core +1 more source
Drug approval processes: A case study of rivaroxaban
Archives of Pharmacy Practice, 2013 Rivaroxaban, a Xa inhibitor, was recently approved (March 2013) in the setting of post-acute coronary syndromes (ACS) by the European Medicine Agency. This is in contrast to not being approved by the Food and Drug Agency in the United States for the same
Sally A Arif, Zainab Bilfaqi
doaj +1 more source
Annals of Internal Medicine, 2020 Supporting U.S. Food and Drug Administration Approval of Cancer Drugs Background: In the United States, African American persons have the highest death rate and lowest survival rate of any racial or ethnic group for most types of cancer.
Samer Al Hadidi +3 more
semanticscholar +1 more source
Sununu\u27s Job Approval Falls From All-Time High; Bipartisan Optimism About NH Overall 4/23/2019 [PDF]
, 2019 Governor Chris Sununu\u27s job approval has declined from an all-time high in February, but his approval mirrors that of his predecessor Maggie Hassan at the same point in her governorship. Only four in ten Democrats approve of Sununu\u27s performance as
UNH Survey Center
core +1 more source
Lack of Transparency in the Premarket Approval Process for Aquadvantage Salmon [PDF]
, 2013 After a lengthy premarket approval process, the Food and Drug Administration (FDA) has just deemed AquAdvantage Salmon, a fast-growing, genetically engineered salmon, safe for human consumption.
McEvilly, Michael P.
core +1 more source
Delayed Access to Generic Medicine: A Comment on the Hatch-Waxman Act and the Approval Bottleneck [PDF]
, 2009 Prescription drug costs can be astronomical. The advent of generic drugs, which sell at substantially lower prices than their brand-name counterparts, can save consumers billions of dollars per year. The Hatch-Waxman Act, which governs the introduction
Patel, Ankur N.
core +1 more source
Reporting bias in drug trials submitted to the Food and Drug Administration: review of publication and presentation. [PDF]
, 2008 BackgroundPrevious studies of drug trials submitted to regulatory authorities have documented selective reporting of both entire trials and favorable results.
Bacchetti, Peter +2 more
core +3 more sources
Desirable Characteristics of Hepatitis C Treatment Regimens: A Review of What We Have and What We Need. [PDF]
, 2016 There have been dramatic advancements in the treatment of chronic hepatitis C (HCV) infection. This is largely due to the approval of several direct-acting antiviral agents (DAAs) from a variety of medication classes with novel mechanisms of action ...
Bidell, Monique R +4 more
core +2 more sources
Biologics: Targets & Therapy, 2018 Kenneth Lundstrom PanTherapeutics, Lutry, Switzerland Abstract: Oncolytic viruses have demonstrated selective replication and killing of tumor cells.
Lundstrom K
doaj
A review of the regulatory framework for personalized bacteriophages registration
Вопросы вирусологии, 2020 The increasing trend in antimicrobial resistance of pathogenic bacteria dictates the need for alternative solutions. Bacteriophages are bacterial viruses that kill their hosts during the lifecycle.
N. N. Landyshev +5 more
doaj +1 more source